Behind the science

Global experts Prof. Ronald van Vollenhoven, Prof. Ioannis Parodis and Prof. Andreas Schwarting share their thoughts @SLEuroSociety European #Lupus Meeting on the importance of disease modification to improve outcomes for patients with lupus.

Have you heard about the new, larger Zug office? We are expanding the location to become the European hub for oncology at GSK uniting science, technology and talent to get ahead of disease together. #AheadTogether

87% of people with #lupus who responded to a survey by the @WorldLupusFed reported at least one organ or organ system was affected by the disease. We’re working to lower this figure. Read about advances in lupus management 👇

Meningitis awareness and vaccine innovation will be key to meeting the @WHO goal of defeating bacterial meningitis within a decade #WorldMeningitisDay2022 twitter.com/NatureCustom/s…

Congratulations to our CEO Emma Walmsley and all of the other accomplished women named to @FortuneMagazine’s list of the 50 most powerful women.

Did you know that bacterial meningitis and neonatal sepsis together are bigger killers than malaria, measles and tetanus combined? 👀#DefeatMeningitiss#WorldMeningitisDay202229

At the Institute of Molecular and Computational Medicine (IMCM) at Oxford, we’re bringing together patients, scientists and technology to outsmart complex neurological diseases. #AheadTogether

Did you know that bacterial meningitis and neonatal sepsis combined are the 2nd biggest infectious killers of children globally?

How many people are expected to be aged 60 and above by 2030?

#DYK that RSV leads to 24,000 deaths in adults globally every year? Today, we are in Belfast focusing on the burden on older adults #UNIDOP2022 #RSV2022 🔗gsk.to/3DZgcfyXW